Congressman Morgan Griffith, who chairs the Subcommittee on Health, delivered an opening statement at a legislative hearing focused on public health workforce, rural health, and over-the-counter medicines. The hearing aimed to discuss reauthorization of essential programs that are set to expire at the end of the fiscal year.
Griffith highlighted H.R. 4273, known as the Over-the-Counter Monograph Drug User Fee Amendments (OMUFA), which seeks to streamline regulatory processes for over-the-counter drugs. “This is the first reauthorization of OMUFA,” he noted, emphasizing bipartisan efforts to minimize regulatory burdens and support innovation.
The discussion also covered H.R. 3686, or the SAFE Sunscreen Standards Act, which would prompt the FDA to consider non-animal testing methods for evaluating new sunscreen ingredients. “We are behind other countries in bringing innovative sunscreens to market,” Griffith stated.
Additionally, H.R. 2821 aims to encourage the FDA’s use of non-animal testing methods through updated regulations. Griffith pointed out that this legislation provides companies with more options for cost-effective testing methods.
The hearing addressed two critical reauthorizations: Title VII and Title VIII programs that provide scholarships and educational assistance for students from underserved backgrounds pursuing medical careers. These programs play a vital role in supporting America’s medical workforce.
Legislation promoting telehealth services was also discussed, including reauthorizing grants for healthcare services in rural areas and enhancing telehealth infrastructure nationwide.
Griffith concluded by expressing his anticipation of insights from witnesses about these programs’ significance and ensuring their timely reauthorization.
